Khiron Life Sciences Corp. (KHRNF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | 12.79 Million | 8.01 Million | 9.58 Million | 891.67 Thousand | - | - |
| Cost of Revenue | 6.42 Million | 1 Million | 7.14 Million | 594.31 Thousand | - | - |
| Gross Profit | 6.37 Million | 7 Million | 2.43 Million | 297.36 Thousand | - | - |
| Operating Expenses | 26.15 Million | 30.61 Million | 40.01 Million | 20.19 Million | - | 59.55 Thousand |
| Selling, General and Administrative Expenses | 23.98 Million | 28.4 Million | 35.91 Million | 20.19 Million | - | 59.55 Thousand |
| Research and Development Expenses | 1.21 Million | 1.52 Million | 3.73 Million | - | - | - |
| Other Expenses | 953 Thousand | 677.82 Thousand | 370.04 Thousand | 168.37 Thousand | - | - |
| Cost and Expenses | 32.58 Million | 31.62 Million | 47.16 Million | 20.78 Million | - | 59.55 Thousand |
| Operating Income | -19.78 Million | -23.6 Million | -37.43 Million | -19.89 Million | - | -59.55 Thousand |
| Interest Expense | 445 Thousand | 468 Thousand | - | - | - | - |
| Income Tax Expense | -465 Thousand | 88.98 Thousand | 22.74 Thousand | 78.58 Thousand | - | - |
| Earnings before Tax | -33.59 Million | -23.94 Million | -36.35 Million | -19.72 Million | - | -59.55 Thousand |
| Net Income | -33.12 Million | -24.03 Million | -36.37 Million | -19.8 Million | - | -59.55 Thousand |
| Earnings Per Share Basic | -0.20 | -0.20 | -0.36 | -0.41 | - | -0.31 |
| Earnings Per Share Diluted | -0.20 | -0.20 | -0.36 | -0.41 | - | -0.31 |
| Weighted Average Shares Outstanding | 164.51 Million | 120.29 Million | 101.96 Million | 48.3 Million | 27.75 Million | 189.58 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 164.51 Million | 120.29 Million | 101.96 Million | 48.51 Million | 27.75 Million | 189.58 Thousand |
| Gross Margin | 0.50 | 0.87 | 0.25 | 0.33 | - | - |
| EBIT Margin | -2.50 | -2.80 | -3.81 | -21.93 | - | - |
| Profit Margin | -2.59 | -3.00 | -3.80 | -22.21 | - | - |
| EBITDA | -32.03 Million | -22.43 Million | -36.49 Million | -18.28 Million | -4.46 Million | -59.55 Thousand |
| Earnings Before Tax Margin | -1.55 | -2.94 | -3.91 | -22.31 | - | - |
| Breakdown | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 FY | 2021 Q4 | 2021 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 3.38 Million | 4.47 Million | 4.64 Million | 12.79 Million | 3.63 Million | 3.51 Million |
| Cost of Revenue | 1.73 Million | 2.12 Million | 3.14 Million | 6.42 Million | 2.46 Million | 1.7 Million |
| Gross Profit | 1.65 Million | 2.35 Million | 1.49 Million | 6.37 Million | 1.17 Million | 1.81 Million |
| Operating Expenses | 5.15 Million | 5.46 Million | 6.51 Million | 26.15 Million | 6.19 Million | 6.41 Million |
| Selling, General and Administrative Expenses | 4.6 Million | 4.45 Million | 5.61 Million | - | 5.52 Million | 5.81 Million |
| Research and Development Expenses | 215 Thousand | 618 Thousand | 548 Thousand | - | 371.06 Thousand | 400.21 Thousand |
| Other Expenses | 336 Thousand | 401 Thousand | 349 Thousand | 953 Thousand | 645.65 Thousand | 33.9 Thousand |
| Cost and Expenses | 6.88 Million | 7.58 Million | 9.66 Million | 32.58 Million | 8.66 Million | 8.12 Million |
| Operating Income | -3.44 Million | -3.17 Million | -4.82 Million | -19.25 Million | -3.11 Million | -5.83 Million |
| Interest Expense | 93 Thousand | 33 Thousand | 155 Thousand | 445 Thousand | - | 75 Thousand |
| Income Tax Expense | 125 Thousand | -35 Thousand | -6000.00 | -465 Thousand | -451.91 Thousand | 605.00 |
| Earnings before Tax | -3.45 Million | -2.2 Million | -5.41 Million | -33.59 Million | -19.95 Million | -3.33 Million |
| Net Income | -3.57 Million | -2.17 Million | -5.41 Million | -33.12 Million | -19.5 Million | -3.33 Million |
| Earnings Per Share Basic | -0.02 | -0.01 | -0.03 | - | -0.11 | -0.02 |
| Earnings Per Share Diluted | -0.02 | -0.01 | -0.03 | - | -0.11 | -0.02 |
| Weighted Average Shares Outstanding | 214.52 Million | 186.44 Million | 179.39 Million | 164.51 Million | 179 Million | 177.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 214.52 Million | 186.44 Million | 179.39 Million | 164.51 Million | 179 Million | 177.02 Million |
| Gross Margin | 0.49 | 0.53 | 0.32 | 0.50 | 0.32 | 0.52 |
| EBIT Margin | -0.85 | -0.56 | -0.91 | - | -0.81 | -1.56 |
| Profit Margin | -1.06 | -0.49 | -1.17 | -2.59 | -5.36 | -0.95 |
| EBITDA | -2.88 Million | -2.51 Million | -4.22 Million | - | -2.95 Million | -5.49 Million |
| Earnings Before Tax Margin | -1.02 | -0.71 | -1.04 | -1.50 | -0.86 | -1.66 |
6054
8511
KIT
300694
069620
TCRRF